Assesment of Endometrial Vascularization with Immunohistochemical CD34 Assay in Recurrent Pregnancy Loss: A Case Control Study

Objectives: We compared the endometrial vascularization in hysteroscopic endometrial samplings between recurrent pregnancy loss (RPL) and control group. Study Design: We prospectively evaluated hysteroscopic endometrial samplings from RPL and control groups. CD34 transmembrane protein was used for evaluating endometrial vascularization. The vascularization was assessed based on thickness of vessels, diameter of the largest vessel, and number of vessels per mm2 in CD34-stained slides. Results: There was no significant difference in demographic findings and vascularization, such as largest vessel diameter (p: 0.572), and number of vessels per mm2 (p: 0.982) between the two groups. Conclusion: The cycling endometrium is a highly angiogenic tissue and may play a role in the etiology of RPL. However, we find a weak relationship between endometrial vascularization and RPL.

[1]  Y. Jeve,et al.  Evidence-based management of recurrent miscarriages , 2014, Journal of human reproductive sciences.

[2]  S. Quan,et al.  Decreased endometrial vascularity in patients with antiphospholipid antibodies-associated recurrent miscarriage during midluteal phase. , 2012, Fertility and sterility.

[3]  S. Quenby,et al.  Localization of angiogenic growth factors and their receptors in the human endometrium throughout the menstrual cycle and in recurrent miscarriage. , 2012, Human reproduction.

[4]  M. Goddijn,et al.  Testing for Inherited Thrombophilia in Recurrent Miscarriage , 2011, Seminars in reproductive medicine.

[5]  P. Kuo,et al.  Association of polymorphisms/haplotypes of the genes encoding vascular endothelial growth factor and its KDR receptor with recurrent pregnancy loss. , 2011, Human reproduction.

[6]  Yanhong Yu,et al.  A comparison of endometrial and subendometrial vascularity assessed by three-dimensional ultrasonography and power Doppler angiography between healthy fertile women and women with unexplained primary recurrent miscarriage. , 2011, Fertility and sterility.

[7]  D. Schust,et al.  Recurrent pregnancy loss: etiology, diagnosis, and therapy. , 2009, Reviews in obstetrics & gynecology.

[8]  V. V. van Hinsbergh,et al.  Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions. , 2008, Human reproduction.

[9]  K. Diehl.  Thyroid dysfunction in pregnancy. , 1998, Journal of Perinatal & Neonatal Nursing.

[10]  J. Bevan,et al.  Human vascular endothelium heterogeneity. A comparative study of cerebral and peripheral cultured vascular endothelial cells. , 1997, Stroke.

[11]  N. Rote.  Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. , 1997, Obstetrics and Gynecology.

[12]  A. Keating,et al.  The CD34 antigen: structure, biology, and potential clinical applications. , 1992, Journal of hematotherapy.

[13]  G. Stirrat.  Recurrent miscarriage. , 1990, Lancet.

[14]  I. Hertz-Picciotto,et al.  Incidence of early loss of pregnancy. , 1988, The New England journal of medicine.